American Vanguard Corporation · NYSE:AVD

American Vanguard — Investor Presentation (March 2010)

17 slides from American Vanguard's investor presentation, March 2010

  1. Slide 1: American Vanguard Investor Presentation

    American Vanguard Investor Presentation This presentation contains, in addition to historical information, forward-looking statements. Such statements are based on management’s current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ mater

  2. Slide 2: Presentation Objectives

    Presentation Objectives 2009. . . What Happened? AVD. . . What did you do about it? 2010. . . What still needs to be done? Future. . . Why is it better than the recent past? 2

  3. Slide 3: Q2 Wake-Up Call

    Q2 Wake-Up Call End-Use Demand (Growers/Farmers) ► Credit Crisis Impact Purchasing Restraint ► Commodity Price Volatility Distribution Channel Demand (Distributors & Mid-West Retailers) ► End-User Purchasing Restraint Working Capital Restraint ► High-Cost Fertilizer & Herbicide Write-Offs Chemical S

  4. Slide 4: Balance Sheet Strengthening

    Balance Sheet Strengthening ► Drive down inventory ► Simultaneously drive down debt 120000 100000 80000 60000 Inventory 40000 Revolver Without Write Down 20000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 '08 '08 '08 '08 '09 '09 '09 '09 4

  5. Slide 5: Income Statement Impact

    Income Statement Impact As we scaled back production, in response to soft demand, it was appropriate to adopt a more conservative accounting method ► Expense unabsorbed fixed manufacturing overhead as opposed to charging it to inventory ► Resulted in lower profit in the current period (2009) ► Prude

  6. Slide 6: 2009/2010 Organizational Changes

    2009/2010 Organizational Changes ► Sales & Marketing  National Accounts Manager and 2 New Regional Managers  New incentive compensation program instituted  New Marketing Tools ► Manufacturing  Tailoring production to meet sales forecasts  Identifying additional contract manufacturing opportunit

  7. Slide 7: 2010 Perspectives

    2010 Perspectives ► Distribution channel inventories lowered  Replenishment will be needed ► End-use demand improving, particularly cotton & peanuts ► Better credit availability and stronger commodity prices ► Ample water supplies in Western US Region ► Market demand will require increased producti

  8. Slide 8: Sales & Marketing Initiatives

    Sales & Marketing Initiatives ► Aggressively promote SmartChoice® (granular soil insecticide)  A dual ingredient, general purpose, economical new product ► Aggressively promote Counter® (granular soil insecticide)  For secondary soil insect control in corn & sugar beets ► Aggressively promote Impa

  9. Slide 9: Manufacturing Efficiency

    Manufacturing Efficiency Reduce under absorption of fixed manufacturing costs by increasing capacity utilization via great thru-put; improving processes and minimizing waste generation ► Los Angeles, California  Volume relatively unchanged ► Axis, Alabama  Metam/Vapam® production increase, Folex®

  10. Slide 10: Operating Expenses

    Operating Expenses Selling: Slight increases from marketing promotional programs and sales incentive payments General Administration: Compensation restrain to continue, maintain HR benefits costs RAD/Registration: Modest increases reflect new product development and re-registration costs Freight: Co

  11. Slide 11: Management Discipline

    Management Discipline Inventories: Reduce further from $72 million Cap Ex: Maintain $6-8 million range with all necessary regulatory/environmental/safety requirements Debt: Reduce term debt on schedule ($2 million/quarter) plus revolver maintenance tightly managed 11

  12. Slide 12: Amvac Business Model

    Amvac Business Model Two Prong Approach ► Organic Growth Label expansion, packaging improvement, new formulations, improved marketing programs, field research ► Acquisitions/Licensing Acquire mature brand name products from majors who are focusing on new innovations, license products to expand use b

  13. Slide 13: Ag Chemical Research Projects

    AG CHEMICAL RESEARCH PROJECTS Introduced 1993-2008 R&D Pipeline Bayer 36 6 Syngenta 18 5* BASF 20 4 Dow 21 1 Sumitomo 16 3* DuPont 7 3* Monsanto 1 0 Other Japanese 43 18 Rest 21 5 Total 183 45** * Some in co-development with other companies Source: Phillips McDougall 13 ** Some licensed products cou

  14. Slide 14: New Product Development

    New Product Development (Third Leg of the Stool) ► New product development “Pipeline” more than a dozen candidates, including insecticides, fungicides, herbicides, and growth regulators ► Additional candidates being discussed with others  For shared development funding ► All are targeted at high-va

  15. Slide 15: Proven Experience

    Proven Experience ► Impact – Post Emergent Corn Herbicide  Licensed from BASF in 2005, prior to development completion. Amvac has completed development, formulations, registration, and successful market introduction ► Nuvan® – Board Spectrum Pest Control Insecticide  Existing molecule, Amvac has r

  16. Slide 16: Investment Premise

    Investment Premise ► Strong, solid balance sheet ► Reasonable, sustainable cash-flow ► Improving market conditions ► Disciplined approach to cost/expense control ► Diminishing fixed manufacturing cost issue with higher thru-put 16

  17. Slide 17: Take-Away Message

    Take-Away Message We are going to: ► Sell more effectively ► Manufacture more efficiently ► Manage more economically ► Expand through collaborative arrangements ► Incremental growth with our three legged approach  Organic growth  Acquisition-licensing potential  New product pipeline This strong b

American Vanguard — Investor Presentation (March 2010) on 6ix